Triple
T18213141
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | vincristine |
E436082
|
entity |
| Predicate | usedForTreatmentOf |
P4714
|
FINISHED |
| Object | Burkitt lymphoma |
—
|
NE NERFINISHED |
How this triple was built (3 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Burkitt lymphoma | Statement: [vincristine, usedForTreatmentOf, Burkitt lymphoma]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Burkitt lymphoma Context triple: [vincristine, usedForTreatmentOf, Burkitt lymphoma]
-
A.
Hodgkin lymphoma
Hodgkin lymphoma is a type of cancer that originates in the lymphatic system, characterized by the presence of abnormal Reed–Sternberg cells and often affecting lymph nodes.
-
B.
Hodgkin
Hodgkin is a surname most famously associated with Dorothy Hodgkin, the Nobel Prize–winning British chemist who advanced the field of X-ray crystallography.
-
C.
non-Hodgkin lymphoma
Non-Hodgkin lymphoma is a diverse group of blood cancers that originate in the lymphatic system from abnormal lymphocytes and can vary widely in aggressiveness and prognosis.
-
D.
Epstein–Barr virus infection
Epstein–Barr virus infection is a common herpesvirus illness that can cause infectious mononucleosis and is associated with various autoimmune and neurological complications.
-
E.
CLL
CLL is the IATA airport code for Easterwood Airport, a regional airport serving College Station, Texas.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Burkitt lymphoma Target entity description: Burkitt lymphoma is a highly aggressive B-cell non-Hodgkin lymphoma characterized by rapid tumor growth, often affecting the jaw or abdomen, and commonly associated with Epstein–Barr virus infection.
-
A.
Hodgkin lymphoma
Hodgkin lymphoma is a type of cancer that originates in the lymphatic system, characterized by the presence of abnormal Reed–Sternberg cells and often affecting lymph nodes.
-
B.
Hodgkin
Hodgkin is a surname most famously associated with Dorothy Hodgkin, the Nobel Prize–winning British chemist who advanced the field of X-ray crystallography.
-
C.
non-Hodgkin lymphoma
chosen
Non-Hodgkin lymphoma is a diverse group of blood cancers that originate in the lymphatic system from abnormal lymphocytes and can vary widely in aggressiveness and prognosis.
-
D.
Epstein–Barr virus infection
Epstein–Barr virus infection is a common herpesvirus illness that can cause infectious mononucleosis and is associated with various autoimmune and neurological complications.
-
E.
CLL
CLL is the IATA airport code for Easterwood Airport, a regional airport serving College Station, Texas.
- F. None of above.
Provenance (2 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69d8b90dba6481908e119eb9aa4ca0cb |
completed | April 10, 2026, 8:47 a.m. |
| NER | Named-entity recognition | batch_69e4e22a26308190a6720b41a9bbfc2d |
completed | April 19, 2026, 2:09 p.m. |
Created at: April 10, 2026, 10:32 a.m.